Small molecule modulators of MHC class II antigen presentation: Mechanistic insights and implications for therapeutic application

Molecular Immunology

Volumn 48, Issue 15-16, 2011, Pages 1735-1743

  Call, Melissa J ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Antigen presentation; HLA DM; MHC class II; Peptides; Small molecules

Indexed keywords

ADAMANTANE; ADAMANTANE DERIVATIVE; ALCOHOL; CARBOPLATIN; CISPLATIN; HLA DM ANTIGEN; HLA DR1 ANTIGEN; HLA DR2 ANTIGEN; HLA DR4 ANTIGEN; INTERLEUKIN 2; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; METAL COMPLEX; PEPTIDE; PHENYLALANINE;

ALLOSTERISM; AMINO ACID ANALYSIS; ANTIBODY RESPONSE; ANTIGEN PRESENTATION; BINDING SITE; CD4+ T LYMPHOCYTE; CYTOKINE PRODUCTION; HUMAN; HYDROGEN BOND; IMMUNOTHERAPY; MOLECULAR DYNAMICS; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; REVIEW; STRUCTURE ACTIVITY RELATION;

ANIMALS; ANTIGEN PRESENTATION; ANTIGEN-PRESENTING CELLS; CD4-POSITIVE T-LYMPHOCYTES; HISTOCOMPATIBILITY ANTIGENS CLASS II; HUMANS; LYMPHOCYTE ACTIVATION; PEPTIDES;

EID: 80051918929     PISSN: 01615890     EISSN: 18729142     Source Type: Journal    
DOI: 10.1016/j.molimm.2011.05.022     Document Type: Review

References (62)

1. Anders A.K., Call M.J., Schulze M.S., Fowler K.D., Schubert D.A., Seth N.P., Sundberg E.J., Wucherpfennig K.W. HLA-DM captures partially empty HLA-DR molecules for catalyzed removal of peptide. Nat. Immunol. 2011, 12:54-61.
2. Anderson H.A., Bergstralh D.T., Kawamura T., Blauvelt A., Roche P.A. Phosphorylation of the invariant chain by protein kinase C regulates MHC class II trafficking to antigen-processing compartments. J. Immunol. 1999, 163:5435-5443.
3. Baranzini S.E. The genetics of autoimmune diseases: a networked perspective. Curr. Opin. Immunol. 2009, 21:596-605.
4. Behrens G., Li M., Smith C.M., Belz G.T., Mintern J., Carbone F.R., Heath W.R. Helper T cells, dendritic cells and CTL immunity. Immunol. Cell Biol. 2004, 82:84-90.
5. Brown J.H., Jardetzky T.S., Gorga J.C., Stern L.J., Urban R.G., Strominger J.L., Wiley D.C. Three-dimensional structure of the human class II histocompatibility antigen HLA-DR1. Nature 1993, 364:33-39.
6. Busch R., Cloutier I., Sekaly R.P., Hammerling G.J. Invariant chain protects class II histocompatibility antigens from binding intact polypeptides in the endoplasmic reticulum. EMBO J. 1996, 15:418-428.
7. Busch R., Rothbard J.B. Detection of peptide-MHC class II complexes on the surface of intact cells. J. Immunol. Methods 1990, 134:1-22.
8. Call M.J., Xing X., Cuny G.D., Seth N.P., Altmann D.M., Fugger L., Krogsgaard M., Stein R.L., Wucherpfennig K.W. In vivo enhancement of peptide display by MHC class II molecules with small molecule catalysts of peptide exchange. J. Immunol. 2009, 182:6342-6352.
9. Castellino F., Zappacosta F., Coligan J.E., Germain R.N. Large protein fragments as substrates for endocytic antigen capture by MHC class II molecules. J. Immunol. 1998, 161:4048-4057.
10. Chapman H.A. Endosomal proteolysis and MHC class II function. Curr. Opin. Immunol. 1998, 10:93-102.
11. de Kroon A.I., McConnell H.M. Enhancement of peptide antigen presentation by a second peptide. Proc. Natl. Acad. Sci. U.S.A. 1993, 90:8797-8801.
12. De Wall S.L., Painter C., Stone J.D., Bandaranayake R., Wiley D.C., Mitchison T.J., Stern L.J., DeDecker B.S. Noble metals strip peptides from class II MHC proteins. Nat. Chem. Biol. 2006, 2:197-201.
13. Delamarre L., Couture R., Mellman I., Trombetta E.S. Enhancing immunogenicity by limiting susceptibility to lysosomal proteolysis. J. Exp. Med. 2006, 203:2049-2055.
14. Denzin L.K., Cresswell P. HLA-DM induces CLIP dissociation from MHC class II alpha beta dimers and facilitates peptide loading. Cell 1995, 82:155-165.
15. Denzin L.K., Hammond C., Cresswell P. HLA-DM interactions with intermediates in HLA-DR maturation and a role for HLA-DM in stabilizing empty HLA-DR molecules. J. Exp. Med. 1996, 184:2153-2165.
16. Dickhaut K., Hoepner S., Eckhard J., Wiesmueller K.H., Schindler L., Jung G., Falk K., Roetzschke O. Enhancement of tumour-specific immune responses in vivo by 'MHC loading-enhancer' (MLE). PLoS One 2009, 4:e6811.
17. Doebele R.C., Busch R., Scott H.M., Pashine A., Mellins E.D. Determination of the HLA-DM interaction site on HLA-DR molecules. Immunity 2000, 13:517-527.
18. Falk K., Lau J.M., Santambrogio L., Esteban V.M., Puentes F., Rotzschke O., Strominger J.L. Ligand exchange of major histocompatibility complex class II proteins is triggered by H-bond donor groups of small molecules. J. Biol. Chem. 2002, 277:2709-2715.
19. Ferrante A., Anderson M.W., Klug C.S., Gorski J. HLA-DM mediates epitope selection by a " compare-exchange" mechanism when a potential peptide pool is available. PLoS One 2008, 3:e3722.
20. Ferrante A., Gorski J. Cutting edge: HLA-DM-mediated peptide exchange functions normally on MHC class II-peptide complexes that have been weakened by elimination of a conserved hydrogen bond. J. Immunol. 2010, 184:1153-1158.
21. Fremont D.H., Hendrickson W.A., Marrack P., Kappler J. Structures of an MHC class II molecule with covalently bound single peptides. Science 1996, 272:1001-1004.
22. Grotenbreg G.M., Nicholson M.J., Fowler K.D., Wilbuer K., Octavio L., Yang M., Chakraborty A.K., Ploegh H.L., Wucherpfennig K.W. Empty class II major histocompatibility complex created by peptide photolysis establishes the role of DM in peptide association. J. Biol. Chem. 2007, 282:21425-21436.
23. Gupta S., Hopner S., Rupp B., Gunther S., Dickhaut K., Agarwal N., Cardoso M.C., Kuhne R., Wiesmuller K.H., Jung G., Falk K., Rotzschke O. Anchor side chains of short peptide fragments trigger ligand-exchange of class II MHC molecules. PLoS One 2008, 3:e1814.
24. Hopner S., Dickhaut K., Hofstatter M., Kramer H., Ruckerl D., Soderhall J.A., Gupta S., Marin-Esteban V., Kuhne R., Freund C., Jung G., Falk K., Rotzschke O. Small organic compounds enhance antigen loading of class II major histocompatibility complex proteins by targeting the polymorphic P1 pocket. J. Biol. Chem. 2006, 281:38535-38542.
25. Katz J.F., Stebbins C., Appella E., Sant A.J. Invariant chain and DM edit self-peptide presentation by major histocompatibility complex (MHC) class II molecules. J. Exp. Med. 1996, 184:1747-1753.
26. Kropshofer H., Arndt S.O., Moldenhauer G., Hammerling G.J., Vogt A.B. HLA-DM acts as a molecular chaperone and rescues empty HLA-DR molecules at lysosomal pH. Immunity 1997, 6:293-302.
27. Kropshofer H., Vogt A.B., Moldenhauer G., Hammer J., Blum J.S., Hammerling G.J. Editing of the HLA-DR-peptide repertoire by HLA-DM. EMBO J. 1996, 15:6144-6154.
28. Kropshofer H., Vogt A.B., Stern L.J., Hammerling G.J. Self-release of CLIP in peptide loading of HLA-DR molecules. Science 1995, 270:1357-1359.
29. Lanzavecchia A., Reid P.A., Watts C. Irreversible association of peptides with class II MHC molecules in living cells. Nature 1992, 357:249-252.
30. Liang M.N., Beeson C., Mason K., McConnell H.M. Kinetics of the reactions between the invariant chain (85-99) peptide and proteins of the murine class II MHC. Int. Immunol. 1995, 7:1397-1404.
31. Marin-Esteban V., Falk K., Rotzschke O. Small-molecular compounds enhance the loading of APC with encephalitogenic MBP protein. J. Autoimmun. 2003, 20:63-69.
32. Marin-Esteban V., Falk K., Rotzschke O. " Chemical analogues" of HLA-DM can induce a peptide-receptive state in HLA-DR molecules. J. Biol. Chem. 2004, 279:50684-50690.
33. McFarland B.J., Katz J.F., Sant A.J., Beeson C. Energetics and cooperativity of the hydrogen bonding and anchor interactions that bind peptides to MHC class II protein. J. Mol. Biol. 2005, 350:170-183.
34. McMartin C. Molecular sieving, receptor processing and peptidolysis as major determinants of peptide pharmacokinetics in vivo. Biochem. Soc. Trans. 1989, 17:931-934.
35. Mellins E., Smith L., Arp B., Cotner T., Celis E., Pious D. Defective processing and presentation of exogenous antigens in mutants with normal HLA class II genes. Nature 1990, 343:71-74.
36. Menges P.R., Jenks S.A., Bikoff E.K., Friedmann D.R., Knowlden Z.A., Sant A.J. An MHC class II restriction bias in CD4 T cell responses toward I-A is altered to I-E in DM-deficient mice. J. Immunol. 2008, 180:1619-1633.
37. Nanda N.K., Sant A.J. DM determines the cryptic and immunodominant fate of T cell epitopes. J. Exp. Med. 2000, 192:781-788.
38. Narayan K., Chou C.L., Kim A., Hartman I.Z., Dalai S., Khoruzhenko S., Sadegh-Nasseri S. HLA-DM targets the hydrogen bond between the histidine at position beta81 and peptide to dissociate HLA-DR-peptide complexes. Nat. Immunol. 2007, 8:92-100.
39. Nelson C.A., Vidavsky I., Viner N.J., Gross M.L., Unanue E.R. Amino-terminal trimming of peptides for presentation on major histocompatibility complex class II molecules. Proc. Natl. Acad. Sci. U.S.A. 1997, 94:628-633.
40. Nicholson M.J., Moradi B., Seth N.P., Xing X., Cuny G.D., Stein R.L., Wucherpfennig K.W. Small molecules that enhance the catalytic efficiency of HLA-DM. J. Immunol. 2006, 176:4208-4220.
41. Painter C.A., Cruz A., Lopez G.E., Stern L.J., Zavala-Ruiz Z. Model for the peptide-free conformation of class II MHC proteins. PLoS One 2008, 3:e2403.
42. Pashine A., Busch R., Belmares M.P., Munning J.N., Doebele R.C., Buckingham M., Nolan G.P., Mellins E.D. Interaction of HLA-DR with an acidic face of HLA-DM disrupts sequence-dependent interactions with peptides. Immunity 2003, 19:183-192.
43. Pedrazzini T., Sette A., Albertson M., Grey H.M. Free ligand-induced dissociation of MHC-antigen complexes. J. Immunol. 1991, 146:3496-3501.
44. Pinet V.M., Long E.O. Peptide loading onto recycling HLA-DR molecules occurs in early endosomes. Eur. J. Immunol. 1998, 28:799-804.
45. Rabinowitz J.D., Vrljic M., Kasson P.M., Liang M.N., Busch R., Boniface J.J., Davis M.M., McConnell H.M. Formation of a highly peptide-receptive state of class II MHC. Immunity 1998, 9:699-709.
46. Rudensky A.Y., Maric M., Eastman S., Shoemaker L., DeRoos P.C., Blum J.S. Intracellular assembly and transport of endogenous peptide-MHC class II complexes. Immunity 1994, 1:585-594.
47. Sakaguchi S., Miyara M., Costantino C.M., Hafler D.A. FOXP3+ regulatory T cells in the human immune system. Nat. Rev. Immunol. 2010, 10:490-500.
48. Sette A., Southwood S., Miller J., Appella E. Binding of major histocompatibility complex class II to the invariant chain-derived peptide CLIP, is regulated by allelic polymorphism in class II. J. Exp. Med. 1995, 181:677-683.
49. Sherman M.A., Weber D.A., Jensen P.E. DM enhances peptide binding to class II MHC by release of invariant chain-derived peptide. Immunity 1995, 3:197-205.
50. Sloan V.S., Cameron P., Porter G., Gammon M., Amaya M., Mellins E., Zaller D.M. Mediation by HLA-DM of dissociation of peptides from HLA-DR. Nature 1995, 375:802-806.
51. Stebbins C.C., Loss G.E., Elias C.G., Chervonsky A., Sant A.J. The requirement for DM in class II-restricted antigen presentation and SDS-stable dimer formation is allele and species dependent. J. Exp. Med. 1995, 181:223-234.
52. Stern L.J., Brown J.H., Jardetzky T.S., Gorga J.C., Urban R.G., Strominger J.L., Wiley D.C. Crystal structure of the human class II MHC protein HLA-DR1 complexed with an influenza virus peptide. Nature 1994, 368:215-221.
53. Stratikos E., Wiley D.C., Stern L.J. Enhanced catalytic action of HLA-DM on the exchange of peptides lacking backbone hydrogen bonds between their N-terminal region and the MHC class II alpha-chain. J. Immunol. 2004, 172:1109-1117.
54. Vinuesa C.G., Tangye S.G., Moser B., Mackay C.R. Follicular B helper T cells in antibody responses and autoimmunity. Nat. Rev. Immunol. 2005, 5:853-865.
55. Vogt A.B., Kropshofer H., Moldenhauer G., Hammerling G.J. Kinetic analysis of peptide loading onto HLA-DR molecules mediated by HLA-DM. Proc. Natl. Acad. Sci. U.S.A. 1996, 93:9724-9729.
56. Vogt A.B., Moldenhauer G., Hammerling G.J., Kropshofer H. HLA-DM stabilizes empty HLA-DR molecules in a chaperone-like fashion. Immunol. Lett. 1997, 57:209-211.
57. Weber D.A., Evavold B.D., Jensen P.E. Enhanced dissociation of HLA-DR-bound peptides in the presence of HLA-DM. Science 1996, 274:618-620.
58. Xu M., Jackson R., Adams S., Humphreys R.E. Studies on activities of invariant chain peptides on releasing or exchanging of antigenic peptides at human leukocyte antigen-DR1. Arzneimittelforschung 1999, 49:791-799.
59. Zaheer ul H., Khan W. Molecular and structural determinants of adamantyl susceptibility to HLA-DRs allelic variants: an in silico approach to understand the mechanism of MLEs. J. Comput. Aided Mol. Des. 2011, 25:81-101.
60. Zarutskie J.A., Busch R., Zavala-Ruiz Z., Rushe M., Mellins E.D., Stern L.J. The kinetic basis of peptide exchange catalysis by HLA-DM. Proc. Natl. Acad. Sci. U.S.A. 2001, 98:12450-12455.
61. Zhou Z., Callaway K.A., Weber D.A., Jensen P.E. Cutting edge: HLA-DM functions through a mechanism that does not require specific conserved hydrogen bonds in class II MHC-peptide complexes. J. Immunol. 2009, 183:4187-4191.
62. Zhu J., Paul W.E. CD4 T cells: fates, functions, and faults. Blood 2008, 112:1557-1569.